GRAZIOSO, GIOVANNI
GRAZIOSO, GIOVANNI
Dipartimento di Scienze Farmaceutiche
Photoswitchable glycomimetics enable precision targeting of LecB in Pseudomonas aeruginosa
2026 A. Colleoni, S. Bhattacharya, E.M.A. Fassi, G. Tempra, G. Valsecchi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Protein language model-generated enzyme sequences exhibit high stability in molecular dynamics simulations
2026 E.M.A. Fassi, M. Nicolini, E. Saitto, G. Valentini, E. Casiraghi, G. Grazioso
Finenzyme-generated enzymes with predicted structures (ESMfold)
2026 M. Nicolini, E. Fassi, G. Valentini, E. Casiraghi, G. Grazioso
PCSK9 inhibitors: an updated patent review 2024–2025
2026 E.M.A. Fassi, M. Albani, L. D'Adduzio, E.G. Milano, C. Lammi, G. Grazioso
Spatiotemporal Control of Inflammation via Light-Responsive Anti-Inflammatory Agents
2026 A. Pérez-Sánchez, A. Morales, A. Cruz, D. D’Avino, G. Galassi, E.G. Milano, I. Bernareggi, G. Grazioso, R. Alibés, J. Hernando, P. Gorostiza, A. Rossi, A. Pistocchi, C. Matera, F. Busqué, À.G. 1, J.M. Lluch
Targeting Pseudomonas aeruginosa LecB with Photoswitchable Glycomimetic Ligands
2026 A. Colleoni, S. Bhattacharya, G. Tempra, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Development of In-Cell Self-Assembly Proteolysis Targeting Chimeras Exploiting the Biorthogonal Reaction Between Vinyl Boronic Acids and 1,2,4,5-Tetrazines
2026 M. Galli, L. Passarelli, E. Fassi, G. Grazioso, D. Passarella, A. Silvani
Synthesis of Self-Assembling Proteolysis Targeting Chimeras Based on Biorthogonal Reactions
2026 M. Galli, L. Passarelli, A. Silvani, G. Grazioso, E. Fassi
Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources
2026 L. Legnani, M. Gargiulo, E. Lio, E.M.A. Fassi, G. Grazioso, M.A. Chiacchio, B. Binay, S. Brocca, F. Secundo
Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents
2026 A. Morales, A. Cruz, Á. Pérez-Sánchez, D. D'Avino, G. Galassi, E.G. Milano, I. Bernareggi, C. Arenós-Bach, G. Grazioso, R. Alibés, J. Hernando, P. Gorostiza, A. Rossi, A. Pistocchi, C. Matera, F. Busqué, À. González-Lafont, J.M. Lluch
Breakable Organosilica Nanocapsules for the Intracellular Delivery of a Peptide With Promising Anti‐Breast Cancer Activity
2026 S. Mathlouthi, A. Ajò, E.M.A. Fassi, A. Cagnotto, A. Fragassi, C. Pesce, M. Garofalo, L. De Cola, G. Grazioso
Design, synthesis and characterization of novel potential TAU-degraders
2026 G. Tempra, E.M.A. Fassi, G. Grazioso, P. Seneci, D. Passarella
A nicotinic-dopaminergic hybrid probe enhances D2-like autoreceptor-mediated inhibition of dopamine release
2026 C. Matera, M. Grilli, L. Pucci, E.M.A. Fassi, S. Fucile, M. Marchi, C. Fiorentini, F. Clementi, M. Zoli, C. Dallanoce, G. Grazioso, M. De Amici, C. Gotti
A Novel Approach to Target a Previously Unexplored Pocket in PI3Kgamma
2026 A. Casale, A. Mainetti, G. Antonini, G. Grazioso, C. Borsari
Structure-guided design of an LC3B-targeting PNA oligomer modulating autophagy and LC3B-mediated mRNA decay
2026 M. Albani, E.M.A. Fassi, A. Romanelli, M. Montagnani Marelli, M. Garofalo, G. Roda, R.M. Moretti, G. Grazioso
Spatiotemporal Control of Bacterial Adhesion via Light-Responsive Modulators
2025 A. Colleoni, G. Tempra, S. Bhattacharya, E.M.A. Fassi, M. De Amici, G. Grazioso, R. Castagna, E. Parisini, C. Matera
Design and synthesis of CD70 inhibitors: a potential way for the treatment of ulcerative colitis
2025 M. Galli, A. Silvani, G. Grazioso, E.G. Milano, E.M.A. Fassi, M. Bramuzzo, A. Muzzo, G. Stocco, M. Lucafò
Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation
2025 C. Catto', E.M.A. Fassi, G. Grazioso, A. Gelain, S. Villa, F. Cappitelli
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation
2025 M. Mori, E.M.A. Fassi, F. Villa, E.G. Milano, F. Forlani, F. Cappitelli, A. Ratti, F. Meneghetti, G. Roda, G. Grazioso, S. Villa
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation
2025 G. Cazzaniga, D. Capelli, R. Montanari, E.M.A. Fassi, G. Grazioso, A. Tresoldi, F. Rinaldi, E. Calleri, I. Bassanini, S. Romeo, M. Garofalo, M. Mori, F. Meneghetti, S. Villa